Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Sollers reported for 3 months of 2025 by RAS

5/5/25 SVAV

Yuzhuralzoloto reported for 3 months of 2025 by RAS

5/5/25 UGLD

Board of Directors of Rosseti Tomsk recommended that dividends be paid for 2024

5/5/25 TORS

Tatneft reported for 3 months of 2025 by RAS

5/5/25 TATN

X5 reported for 3 months of 2025 by IFRS

5/5/25 X5

Board of Directors of Krasnoyarskenergosbyt recommended that dividends be paid for 2024

5/5/25 KRSB

Rosseti Urals reported for 3 months of 2025 by RAS

5/5/25 MRKU

Board of Directors of Far-Eastern Energy Company recommended that dividends be paid for 2024

5/5/25 DVEC

JSFC Sistema has transferred control over Voskhod

5/5/25 AFKS

Buryatzoloto reported for 2024 by IFRS

5/1/25 BRZL